Medicines for children--the last century and the next.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Do Paediatric Investigation Plans (PIPs) Advance Paediatric Healthcare?Paediatric drugs · 2017
   Article
2. Insufficient access to oral paediatric medicines in Ghana: A descriptive study.BMC health services research · 2016
   Article
3. Off-label drug use in a Pediatric Intensive Care Unit.Indian journal of pediatrics · 2009
   Article
4. The EU's new paediatric medicines legislation: serving children's needs?Archives of disease in childhood · 2007
   Review
5. The future of neonatal therapeutic trials.Archives of disease in childhood. Fetal and neonatal edition · 2006
   Review
6. Dose estimation for children.British journal of clinical pharmacology · 2003
   Review
7. Unlicensed and off-label drug use: issues and recommendations.Paediatric drugs · 2002
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as